In vivo transcriptomic profiling using cell encapsulation identifies effector pathways of systemic aging
Abstract
Sustained exposure to a young systemic environment rejuvenates aged organisms and promotes cellular function. However, due to the intrinsic complexity of tissues it remains challenging to pinpoint niche-independent effects of circulating factors on specific cell populations. Here we describe a method for the encapsulation of human and mouse skeletal muscle progenitors in diffusible polyethersulfone hollow fiber capsules that can be used to profile systemic aging in vivo independent of heterogeneous short-range tissue interactions. We observed that circulating long-range signaling factors in the old systemic environment lead to an activation of Myc and E2F transcription factors, induce senescence and suppress myogenic differentiation. Importantly, in vitro profiling using young and old serum in 2D culture does not capture all pathways deregulated in encapsulated cells in aged mice. Thus, in vivo transcriptomic profiling using cell encapsulation allows for the characterization of effector pathways of systemic aging with unparalleled accuracy.
Data availability
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (GEO). GEO Series accession numbers are GSE111401, GSE81096 and GSE193665.
-
In Vivo Transcriptomic Profiling using Cell Encapsulation Identifies Effector Pathways of Systemic AgingNCBI Gene Expression Omnibus, GSE111401.
-
In Vivo Transcriptomic Profiling using Cell Encapsulation Identifies Effector Pathways of Systemic AgingNCBI Gene Expression Omnibus, GSE193665.
Article and author information
Author details
Funding
Canadian Institutes of Health Research (PJT-162442)
- C Florian Bentzinger
Association Française contre les Myopathies (AFM)
- Pura Muñoz-Cánoves
MWRF (MWRF)
- Pura Muñoz-Cánoves
Maria de Maeztu Unit of Excellence award to UPF (MDM-2014-0370)
- Pura Muñoz-Cánoves
Severo Ochoa Center of Excellence award to the CNIC (SEV-2015-0505)
- Pura Muñoz-Cánoves
Severo Ochoa FPI predoctoral fellowship (SEV-2015-0505-17-1))
- Xiaotong Hong
National Science and Research Council of Canada (RGPIN-2017-05490)
- C Florian Bentzinger
Fonds de Recherche du Québec - Santé (Dossiers 296357,34813,and 36789)
- C Florian Bentzinger
Centre de Recherche Médicale de l'Université de Sherbrooke (CRMUS Chair)
- C Florian Bentzinger
European Research Council (ERC-2016-AdG-741966)
- Pura Muñoz-Cánoves
La Caixa Foundation (La Caixa-HEALTH-HR17-00040)
- Pura Muñoz-Cánoves
Muscular Dystrophy Association (MDA)
- Pura Muñoz-Cánoves
H2020 (UPGRADE-H2020-825825)
- Pura Muñoz-Cánoves
Programa Estatal de Investigacion (RTI2018-096068-B-I00)
- Pura Muñoz-Cánoves
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: This study was performed in accordance with the Swiss regulation on animal experimentation and the European Community Council directive (86/609/EEC) for the care and use of laboratory animals. Experiments were approved by the Vaud cantonal authorities under license VD3085, and by the Animal Care and Ethics Committee of the Spanish National Cardiovascular Research Center (CNIC) and regional authorities.
Copyright
© 2022, Mashinchian et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,244
- views
-
- 338
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Recent studies showed an unexpected complexity of extracellular vesicle (EV) biogenesis pathways. We previously found evidence that human colorectal cancer cells in vivo release large multivesicular body-like structures en bloc. Here, we tested whether this large EV type is unique to colorectal cancer cells. We found that all cell types we studied (including different cell lines and cells in their original tissue environment) released multivesicular large EVs (MV-lEVs). We also demonstrated that upon spontaneous rupture of the limiting membrane of the MV-lEVs, their intraluminal vesicles (ILVs) escaped to the extracellular environment by a ‘torn bag mechanism’. We proved that the MV-lEVs were released by ectocytosis of amphisomes (hence, we termed them amphiectosomes). Both ILVs of amphiectosomes and small EVs separated from conditioned media were either exclusively CD63 or LC3B positive. According to our model, upon fusion of multivesicular bodies with autophagosomes, fragments of the autophagosomal inner membrane curl up to form LC3B positive ILVs of amphisomes, while CD63 positive small EVs are of multivesicular body origin. Our data suggest a novel common release mechanism for small EVs, distinct from the exocytosis of multivesicular bodies or amphisomes, as well as the small ectosome release pathway.
-
- Cell Biology
Discovering new strategies to combat the multidrug-resistant bacteria constitutes a major medical challenge of our time. Previously, artesunate (AS) has been reported to exert antibacterial enhancement activity in combination with β-lactam antibiotics via inhibition of the efflux pump AcrB. However, combination of AS and colistin (COL) revealed a weak synergistic effect against a limited number of strains, and few studies have further explored its possible mechanism of synergistic action. In this article, we found that AS and EDTA could strikingly enhance the antibacterial effects of COL against mcr-1- and mcr-1+ Salmonella strains either in vitro or in vivo, when used in triple combination. The excellent bacteriostatic effect was primarily related to the increased cell membrane damage, accumulation of toxic compounds and inhibition of MCR-1. The potential binding sites of AS to MCR-1 (THR283, SER284, and TYR287) were critical for its inhibition of MCR-1 activity. Additionally, we also demonstrated that the CheA of chemosensory system and virulence-related protein SpvD were critical for the bacteriostatic synergistic effects of the triple combination. Selectively targeting CheA, SpvD, or MCR using the natural compound AS could be further investigated as an attractive strategy for the treatment of Salmonella infection. Collectively, our work opens new avenues toward the potentiation of COL and reveals an alternative drug combination strategy to overcome COL-resistant bacterial infections.